×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PHGE – biomx inc. common stock (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PHGE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
08:48 am
phge
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations
Medium
Report
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations
3/19
09:15 am
phge
BiomX CEO Issues Letter to Stockholders
Low
Report
BiomX CEO Issues Letter to Stockholders
3/9
12:23 pm
phge
BiomX appoints Michael Oster as CEO David Rokach as CFO [Seeking Alpha]
Medium
Report
BiomX appoints Michael Oster as CEO David Rokach as CFO [Seeking Alpha]
3/9
09:12 am
phge
BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth [Yahoo! Finance]
Medium
Report
BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth [Yahoo! Finance]
3/9
09:00 am
phge
BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth
Medium
Report
BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth
1/27
01:41 pm
phge
BiomX Issues Statement Regarding Recent Common Stock Trading Activity
Medium
Report
BiomX Issues Statement Regarding Recent Common Stock Trading Activity
12/29
02:06 pm
phge
All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy [Yahoo! Finance]
Neutral
Report
All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy [Yahoo! Finance]
12/29
08:12 am
phge
BiomX Announces $3.0 Million Private Placement [Yahoo! Finance]
Medium
Report
BiomX Announces $3.0 Million Private Placement [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/25
07:07 pm
phge
Form DEF 14A BiomX Inc. For: Apr 10
Medium
Report
Form DEF 14A BiomX Inc. For: Apr 10
3/19
09:26 am
phge
Form 8-K BiomX Inc. For: Mar 13
Low
Report
Form 8-K BiomX Inc. For: Mar 13
3/18
05:48 pm
phge
Form 4 BiomX Inc. For: Mar 16 Filed by: Yeganeh Reuven
Low
Report
Form 4 BiomX Inc. For: Mar 16 Filed by: Yeganeh Reuven
3/13
04:30 pm
phge
Form 4 BiomX Inc. For: Mar 11 Filed by: Yeganeh Reuven
Medium
Report
Form 4 BiomX Inc. For: Mar 11 Filed by: Yeganeh Reuven
3/11
04:24 pm
phge
Form 8-K BiomX Inc. For: Mar 11
Low
Report
Form 8-K BiomX Inc. For: Mar 11
3/6
08:55 am
phge
Form 8-K BiomX Inc. For: Mar 04
Medium
Report
Form 8-K BiomX Inc. For: Mar 04
3/3
09:28 pm
phge
Form 3 BiomX Inc. For: Feb 13 Filed by: Bidas Liat Cohavi
High
Report
Form 3 BiomX Inc. For: Feb 13 Filed by: Bidas Liat Cohavi
3/2
04:07 pm
phge
Form 8-K BiomX Inc. For: Feb 24
High
Report
Form 8-K BiomX Inc. For: Feb 24
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/19
Chardan Acts as M&A Advisor in Health Sciences Acquisitions Corporation Completed Merger with Immunovant
12.2%
12/30 Form 4 BiomX Inc. For: Dec 20 Filed by: GROSSMAN JONAS 10.8%
4/25 BiomX Inc. (NASDAQ: PHGE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.5%
3/26 BiomX Reports Full Year 2019 Financial Results and Provides Business Update 7.4%
2/17 BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference 3.9%
3/27 Form 4 BiomX Inc. For: Mar 25 Filed by: Wolfson Marina 3.1%
12/12 Form 4 BiomX Inc. For: Dec 10 Filed by: OrbiMed Israel GP Ltd. 2.3%
3/20 BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting 2.2%
12/2 BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin 1.8%
1/15 Form 3 BiomX Inc. For: Jan 15 Filed by: Wolfson Marina 1.7%
12/30 Form 4 BiomX Inc. For: Dec 20 Filed by: GROSSMAN JONAS 10.8%
4/25 BiomX Inc. (NASDAQ: PHGE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.5%
3/26 BiomX Reports Full Year 2019 Financial Results and Provides Business Update 7.4%
2/17 BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference 3.9%
3/27 Form 4 BiomX Inc. For: Mar 25 Filed by: Wolfson Marina 3.1%
12/12 Form 4 BiomX Inc. For: Dec 10 Filed by: OrbiMed Israel GP Ltd. 2.3%
3/20 BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting 2.2%
12/2 BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin 1.8%
1/15 Form 3 BiomX Inc. For: Jan 15 Filed by: Wolfson Marina 1.7%
TOP News Decliners
3/31
BiomX Announces Positive Topline Data from Phase 1 Study for Lead Candidate BX001 for Acne-Prone Skin
-9.3%
11/7 Form 3 BiomX Inc. For: Oct 28 Filed by: Woodman Robbie -8.3%
11/12 Form 3 BiomX Inc. For: Nov 04 Filed by: Sullivan Lynne Marie -5.7%
11/12 Stone Street Group Initiates Coverage On BiomX Inc. -5.5%
11/5 Form 3 BiomX Inc. For: Oct 28 Filed by: TAKEDA PHARMACEUTICAL CO LTD -3.9%
11/1 Form 8-K BiomX Inc. For: Oct 28 -3.2%
1/8 BiomX Inc. (NASDAQ: PHGE) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. -3.2%
11/20 Form 4 BiomX Inc. For: Nov 18 Filed by: GROSSMAN JONAS -3.0%
2/3 BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange -2.8%
11/4 BiomX Appoints Russell G. Greig, Ph.D, as Chairman of the Board of Directors and Lynne Sullivan as Board Director -2.8%
11/7 Form 3 BiomX Inc. For: Oct 28 Filed by: Woodman Robbie -8.3%
11/12 Form 3 BiomX Inc. For: Nov 04 Filed by: Sullivan Lynne Marie -5.7%
11/12 Stone Street Group Initiates Coverage On BiomX Inc. -5.5%
11/5 Form 3 BiomX Inc. For: Oct 28 Filed by: TAKEDA PHARMACEUTICAL CO LTD -3.9%
11/1 Form 8-K BiomX Inc. For: Oct 28 -3.2%
1/8 BiomX Inc. (NASDAQ: PHGE) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. -3.2%
11/20 Form 4 BiomX Inc. For: Nov 18 Filed by: GROSSMAN JONAS -3.0%
2/3 BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange -2.8%
11/4 BiomX Appoints Russell G. Greig, Ph.D, as Chairman of the Board of Directors and Lynne Sullivan as Board Director -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: